Google Übersetzer
Obi Pharma, Inc.
About
30.35TWD-1.30 -4.11%
Live at 11:19 GMT+00:00Market Cap$132.10M
Volume847.3K
Beta-0.14
RSI26.94
Gross Margin-621.70%
Obi Pharma, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Jan 12 2026
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Sep 2 2025
OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors
Jun 6 2025
OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies
May 1 2025
OBI Pharma Announces U.S. FDA Clearance of IND Application for a Phase 1/2 Study of OBI-902, a Trop-2 Targeting ADC
Recent Videos
「昔日生技股王」浩鼎生技累計虧損78億 減資50%補大洞｜NOWNEWS #CC字幕
Sep 02, 2025
OBI Pharma旗下ADC药物OBI 992成功获FDA批准，迈向临床新篇章
Jan 10, 2024
【2014/12/8】Introduction of OBI PHARMA, INC ’s
Oct 20, 2022
Wong Chi Huey prosecuted for bribery in OBI Pharma Case 20170110 公視晨間新聞
Jan 10, 2017
Community Chat
Ask AI
Try asking